{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:55:32Z","timestamp":1765727732664},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,21]],"date-time":"2013-07-21T00:00:00Z","timestamp":1374364800000},"content-version":"vor","delay-in-days":3003,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.curtheres.2005.06.010","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T09:26:36Z","timestamp":1298107596000},"page":"154-171","source":"Crossref","is-referenced-by-count":10,"title":["Relative efficacy and interchangeability ofvarious clobetasol propionate vehicles in the management of steroid-responsive dermatoses"],"prefix":"10.1016","volume":"66","author":[{"given":"Steven R.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2005.06.010_bib1","first-page":"2319","article-title":"Principles of topical therapy","volume":"vol 2","author":"Strober","year":"2003"},{"key":"10.1016\/j.curtheres.2005.06.010_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.pa.29.040189.000415","article-title":"Percutaneous absorption of drugs","volume":"29","author":"Stoughton","year":"1989","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"10.1016\/j.curtheres.2005.06.010_bib3","first-page":"2324","article-title":"Topical glucocorticoids","volume":"vol 2","author":"Valencia","year":"2003"},{"issue":"Suppl 2","key":"10.1016\/j.curtheres.2005.06.010_bib4","first-page":"4","article-title":"Topical corticosteroids in clinical practice: Focus on fluticasone propionate","volume":"57","author":"Piacquadio","year":"1996","journal-title":"Cutis"},{"key":"10.1016\/j.curtheres.2005.06.010_bib5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0190-9622(90)70148-B","article-title":"Relation of application time to bioactivity of a potent topical glucocorticoid formulation","volume":"22","author":"Stoughton","year":"1990","journal-title":"J Am Acad Dermatol."},{"issue":"Suppl 1","key":"10.1016\/j.curtheres.2005.06.010_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-4362.1992.tb04009.x","article-title":"The vasoconstrictor assay in bioequivalence testing: Practical concerns and recent developments","volume":"31","author":"Stoughton","year":"1992","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.curtheres.2005.06.010_bib7","series-title":"LP. Study no. CG.03.SPR.4637","author":"Galderma Laboratories","year":"1997"},{"key":"10.1016\/j.curtheres.2005.06.010_bib8","first-page":"201","article-title":"Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis","volume":"74","author":"Decroix","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.curtheres.2005.06.010_bib9","first-page":"65","article-title":"Scalp psoriasis: Topical calcipotriol 50 micrograms\/g\/mL solution vs. betamethasone valerate 1% lotion","volume":"20","author":"Duweb","year":"2000","journal-title":"Int J Clin Pharmacol Res."},{"issue":"Suppl 4","key":"10.1016\/j.curtheres.2005.06.010_bib10","first-page":"2","article-title":"A randomized, double-blind, multicenter trial comparing fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, applied twice daily for 4 weeks in the treatment of psoriasis","volume":"67","author":"James","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.curtheres.2005.06.010_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/030006058301100512","article-title":"Clinical comparison of alclometasone dipropionate cream 0.05% with hydrocortisone butyrate cream 0.1% in the treatment of atopic dermatitis in children","volume":"11","author":"Lassus","year":"1983","journal-title":"J Int Med Res."},{"key":"10.1016\/j.curtheres.2005.06.010_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-4362.1984.tb04214.x","article-title":"Alclometasone dipropionate cream 0.05% versus clobetasone butyrate cream 0.05%. A controlled clinical comparison in the treatment of atopicdermatitis in children","volume":"23","author":"Lassus","year":"1984","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.curtheres.2005.06.010_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2133.1997.tb08752.x","article-title":"Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study","volume":"136","author":"Molin","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.curtheres.2005.06.010_bib14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0190-9622(91)70318-V","article-title":"Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitis","volume":"25","author":"Yawalkar","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.curtheres.2005.06.010_bib15","first-page":"36","article-title":"Double-blind double-bind","volume":"3","author":"Bjornberg","year":"1975","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.curtheres.2005.06.010_bib16","first-page":"796","article-title":"Psoriasis: Treatment with a new topical corticosteroid","volume":"17","author":"Kanof","year":"1976","journal-title":"Cutis"},{"key":"10.1016\/j.curtheres.2005.06.010_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2133.1995.tb02711.x","article-title":"Fluticasone propionate 0.05% cream in the treatment of atopic eczema: A multicentre study comparing once-daily treatment and once-daily vehiclecream application versus twice-daily treatment","volume":"133","author":"Bleehen","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.curtheres.2005.06.010_bib18_1","first-page":"284","article-title":"Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream","volume":"32","author":"van Dijk","year":"1983","journal-title":"Cutis"},{"key":"10.1016\/j.curtheres.2005.06.010_bib18_2","first-page":"287","article-title":"Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream","volume":"32","author":"van Dijk","year":"1983","journal-title":"Cutis"},{"key":"10.1016\/j.curtheres.2005.06.010_bib19_1","first-page":"972","article-title":"A comparison of betamethasone benzoate gel and betamethasone valerate cream","volume":"17","author":"Parish","year":"1976","journal-title":"Cutis"},{"key":"10.1016\/j.curtheres.2005.06.010_bib19_2","first-page":"984","article-title":"A comparison of betamethasone benzoate gel and betamethasone valerate cream","volume":"17","author":"Parish","year":"1976","journal-title":"Cutis"},{"key":"10.1016\/j.curtheres.2005.06.010_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1185\/03007998209112377","article-title":"Intermittent topical treatment of psoriasis with clobetasol propionate (\u201cDermovate\u201d)","volume":"8","author":"Svartholm","year":"1982","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.curtheres.2005.06.010_bib21","first-page":"262","article-title":"Evaluation of a new halcinonide formulation in the treatment of common dermatoses","volume":"30","author":"Pirozzi","year":"1982","journal-title":"Cutis"},{"key":"10.1016\/j.curtheres.2005.06.010_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/030006057900700514","article-title":"A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) inpsoriasis and other steroid-responsive dermatoses","volume":"7","author":"Afzelius","year":"1979","journal-title":"J Int Med Res."},{"key":"10.1016\/j.curtheres.2005.06.010_bib23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/030006059001800603","article-title":"Once-daily 0.1% mometasone furoate cream versus twice-daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses","volume":"18","author":"Viglioglia","year":"1990","journal-title":"J Int Med Res"},{"key":"10.1016\/j.curtheres.2005.06.010_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1440-0960.2002.00592.x","article-title":"Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis","volume":"43","author":"Freeman","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.curtheres.2005.06.010_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/030006058401200305","article-title":"Treatment of severe or resistant corticosteroid-responsive dermatoses with Diprolene cream","volume":"12","author":"Cabrera","year":"1984","journal-title":"J Int Med Res."},{"key":"10.1016\/j.curtheres.2005.06.010_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/030006058401200209","article-title":"Diprolene cream in the treatment of severe or resistant corticosteroidresponsive dermatoses","volume":"12","author":"Lodolo","year":"1984","journal-title":"J Int Med Res."},{"key":"10.1016\/j.curtheres.2005.06.010_bib27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1365-4362.1999.00782.x","article-title":"Betamethasone valerate foam 0.12%: A novel vehicle with enhanced delivery and efficacy","volume":"38","author":"Franz","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.curtheres.2005.06.010_bib28","series-title":"Presented at the World Congress of Dermatology, 2002; and the European Academy of Dermatology and Venereology","article-title":"Clobetasol propionate 0.05% is equivalent as lotion or emollient cream in atopic dermatitis","author":"Breneman","year":"2003"},{"key":"10.1016\/j.curtheres.2005.06.010_bib29","author":"Galderma Laboratories","year":"2000"},{"key":"10.1016\/j.curtheres.2005.06.010_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","article-title":"Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction","volume":"9","author":"Stern","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.curtheres.2005.06.010_bib31","first-page":"327","article-title":"Patients with psoriasis prefer solution and foam vehicles: A quantitative assessment of vehicle preference","volume":"70","author":"Housman","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.curtheres.2005.06.010_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00128071-200304040-00001","article-title":"Patients' vehicle preference for corticosteroid treatments of scalp psoriasis","volume":"4","author":"Feldman","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.curtheres.2005.06.010_bib33","first-page":"581","article-title":"Patients with psoriasis and their compliance with medication","volume":"41","author":"Richards","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.curtheres.2005.06.010_bib34","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archderm.140.9.1151","article-title":"Twice-weekly topical corticosteroid therapy may reduce atopic dermatitis relapses","volume":"140","author":"Williams","year":"2004","journal-title":"Arch Dermatol"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X05000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X05000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T18:50:32Z","timestamp":1543949432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X05000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0011393X05000639"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2005.06.010","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}